NetraMark vs Tempus AI (2026): Pricing, Features & Which to Choose

Who comes out ahead

Based only on the facts in our directory. The right pick still depends on the job you need done.

Lower starting price
Not comparable
Not comparable: NetraMark does not list a price
Free plan
Tie
Neither has one
Higher rating
Tempus AI
3.8 against 4.3
Same job?
Yes
Both are Healthcare AI tools

Side by side

Compared on	NetraMark	Tempus AI
Our rating	3.8	4.3Better
Starts at	Not listed	Not listed
Free plan	No	No
Category	Healthcare AI	Healthcare AI
Plans	See pricing	See pricing
Key features	NetraAI platform for clinical trial design optimisation Optimal dosage discovery from trial data Identification of ideal treatment populations Effect size improvement analysis Late-phase decision support	Machine learning applied to genomic and clinical data for precision treatment matching One of the largest connected libraries of clinical and molecular data Publicly traded on Nasdaq under the ticker TEM Q1 2026 revenue of $348.1M, up 36.1% year over year 2026 revenue guidance raised to $1.59-$1.60 billion
Pros	Targets the design decisions that determine whether a trial succeeds Publishes an evidence base rather than claims alone Publicly listed, so financials and filings are inspectable	Publicly reported financials give unusual transparency into scale and growth Massive, growing data library strengthens precision-matching over time Strong, consistent revenue growth across both diagnostics and data segments
Cons	No public pricing - enterprise pharma engagement Only relevant to organisations running clinical trials Findings still require clinical and regulatory validation	Pricing runs through insurance billing and enterprise agreements, not published rates Built specifically for precision medicine and oncology, a narrower clinical scope Best suited to institutions already positioned to act on genomic testing results
Company	NetraMark Holdings	Tempus AI, founded 2015

Prices come from each vendor's pricing page, last checked 20260831. Check the vendor before you buy.

FAQ

Questions people ask

Is NetraMark better than Tempus AI?

In our reviews NetraMark scores 3.8 and Tempus AI scores 4.3. The better pick depends on the job. NetraMark: NetraAI analyses clinical trial data to optimise trial design - finding optimal dosage, identifying ideal patient populations and increasing effect size. Tempus AI: Publicly traded on Nasdaq, guiding to $1.6 billion in 2026 revenue.

Which is cheaper, NetraMark or Tempus AI?

NetraMark: see pricing. Tempus AI: see pricing.

Do NetraMark and Tempus AI have free plans?

Neither lists a free plan.

More comparisons

NetraMark compared with

All NetraMark alternatives

Tempus AI compared with

All Tempus AI alternatives